Invitrogen Oligofectamine

Invitrogen Oligofectamine™ Transfection Reagent is a proprietary lipid-based formulation designed for the efficient delivery of oligonucleotides and short interfering RNA (siRNA) into eukaryotic cells. This reagent forms stable complexes with nucleic acids, facilitating their uptake and ensuring high transfection efficiency with minimal cytotoxicity.

• High transfection efficiency: Achieves effective delivery of oligonucleotides and siRNA across a wide range of cell lines, including CHO, HEK-293, NIH 3T3, and HeLa cells.
• Low cytotoxicity: Minimises adverse effects on cell viability, preserving cellular integrity during experiments.
• Simple protocol: Offers a straightforward procedure, reducing preparation time and enhancing reproducibility.
• Reduced oligonucleotide usage: Requires nanomolar quantities of antisense oligonucleotides, conserving valuable resources.
• High-throughput compatibility: Suitable for large-scale applications, facilitating extensive experimental setups.

This transfection reagent is widely utilised in molecular biology, genetics, and biotechnology research, particularly in studies involving gene silencing, RNA interference (RNAi), and functional genomics.

Commonly employed in university laboratories, biomedical research centres, and biotechnology companies, this reagent supports a broad spectrum of scientific investigations.

Invitrogen Oligofectamine™ Transfection Reagent has been a trusted tool in the scientific community for over two decades, maintaining its relevance and effectiveness in contemporary research applications.